Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1997 Sep 02;9418:9932-7. doi: 10.1073/pnas.94.18.9932.
Show Gene links
Show Anatomy links
Modulation of potassium channel function by methionine oxidation and reduction.
Ciorba MA
,
Heinemann SH
,
Weissbach H
,
Brot N
,
Hoshi T
.
???displayArticle.abstract???
Oxidation of amino acid residues in proteins can be caused by a variety of oxidizing agents normally produced by cells. The oxidation of methionine in proteins to methionine sulfoxide is implicated in aging as well as in pathological conditions, and it is a reversible reaction mediated by a ubiquitous enzyme, peptide methionine sulfoxide reductase. The reversibility of methionine oxidation suggests that it could act as a cellular regulatory mechanism although no such in vivo activity has been demonstrated. We show here that oxidation of a methionine residue in a voltage-dependent potassium channel modulates its inactivation. When this methionine residue is oxidized to methionine sulfoxide, the inactivation is disrupted, and it is reversed by coexpression with peptide methionine sulfoxide reductase. The results suggest that oxidation and reduction of methionine could play a dynamic role in the cellular signal transduction process in a variety of systems.
Adelman,
Episodic ataxia results from voltage-dependent potassium channels with altered functions.
1995, Pubmed,
Xenbase
Adelman,
Episodic ataxia results from voltage-dependent potassium channels with altered functions.
1995,
Pubmed
,
Xenbase
Aldrich,
Differences in gating among amino-terminal variants of Shaker potassium channels.
1990,
Pubmed
,
Xenbase
al-Mehdi,
Endothelial cell oxidant generation during K(+)-induced membrane depolarization.
1996,
Pubmed
Antz,
NMR structure of inactivation gates from mammalian voltage-dependent potassium channels.
1997,
Pubmed
Brot,
Enzymatic reduction of protein-bound methionine sulfoxide.
1981,
Pubmed
Brot,
Reduction of N-acetyl methionine sulfoxide: a simple assay for peptide methionine sulfoxide reductase.
1982,
Pubmed
Brüne,
Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways.
1996,
Pubmed
Curran,
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.
1995,
Pubmed
Dean,
Reactive species and their accumulation on radical-damaged proteins.
1993,
Pubmed
Demo,
The inactivation gate of the Shaker K+ channel behaves like an open-channel blocker.
1991,
Pubmed
Duprat,
Susceptibility of cloned K+ channels to reactive oxygen species.
1995,
Pubmed
,
Xenbase
Gibson,
Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.
1996,
Pubmed
Good,
Evidence of neuronal oxidative damage in Alzheimer's disease.
1996,
Pubmed
Hoshi,
Biophysical and molecular mechanisms of Shaker potassium channel inactivation.
1990,
Pubmed
,
Xenbase
Jackson,
Electrolysis-induced myocardial dysfunction. A novel method for the study of free radical mediated tissue injury.
1986,
Pubmed
Jackson,
O2 free radical-mediated myocardial and vascular dysfunction.
1986,
Pubmed
Kukreja,
The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection.
1992,
Pubmed
Levine,
Methionine residues as endogenous antioxidants in proteins.
1996,
Pubmed
Lewis,
Potassium and calcium channels in lymphocytes.
1995,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
López-Barneo,
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels.
1993,
Pubmed
,
Xenbase
Marom,
Mechanism and modulation of inactivation of the Kv3 potassium channel.
1993,
Pubmed
,
Xenbase
Moskovitz,
Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues.
1996,
Pubmed
Moskovitz,
Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins.
1996,
Pubmed
Murrell-Lagnado,
Interactions of amino terminal domains of Shaker K channels with a pore blocking site studied with synthetic peptides.
1993,
Pubmed
,
Xenbase
Pallotta,
Voltage-dependent potassium channels since Hodgkin and Huxley.
1992,
Pubmed
Rahman,
Cloning, sequencing, and expression of the Escherichia coli peptide methionine sulfoxide reductase gene.
1992,
Pubmed
Rattan,
Protein synthesis, posttranslational modifications, and aging.
1992,
Pubmed
Ruppersberg,
Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation.
1991,
Pubmed
,
Xenbase
Sanguinetti,
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
1996,
Pubmed
,
Xenbase
Schlief,
Modification of C-type inactivating Shaker potassium channels by chloramine-T.
1996,
Pubmed
,
Xenbase
Schwarz,
Multiple potassium-channel components are produced by alternative splicing at the Shaker locus in Drosophila.
1988,
Pubmed
Stadtman,
Protein oxidation and aging.
1992,
Pubmed
Stephens,
Cysteine-modifying reagents alter the gating of the rat cloned potassium channel Kv1.4.
1996,
Pubmed
Vega-Saenz de Miera,
Modulation of K+ channels by hydrogen peroxide.
1992,
Pubmed
,
Xenbase
Vogt,
Oxidation of methionyl residues in proteins: tools, targets, and reversal.
1995,
Pubmed
Yu,
Cellular defenses against damage from reactive oxygen species.
1994,
Pubmed
Yu,
Critical evaluation of the free radical theory of aging. A proposal for the oxidative stress hypothesis.
1996,
Pubmed
Zagotta,
Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB.
1990,
Pubmed
,
Xenbase
Zagotta,
Gating of single Shaker potassium channels in Drosophila muscle and in Xenopus oocytes injected with Shaker mRNA.
1989,
Pubmed
,
Xenbase
